HW
WST icon

Hancock Whitney’s West Pharmaceutical WST Stock Holding History

Hancock Whitney’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-691
Closed -$226K – 669
2024
Q4 		$226K Sell
691
-912
-57% -$287K 0.01% 589
2024
Q3 		$481K Sell
1,603
-23,805
-94% -$7.29M 0.02% 446
2024
Q2 		$8.37M Buy
25,408
+451
+2% +$159K 0.28% 78
2024
Q1 		$9.88M Buy
24,957
+1,482
+6% +$548K 0.34% 69
2023
Q4 		$8.27M Buy
+23,475
New +$8.31M 0.31% 78
2022
Q2 		– Sell
-539
Closed -$221K – 682
2022
Q1 		$221K Buy
539
+17
+3% +$6.66K 0.01% 648
2021
Q4 		$245K Buy
522
+24
+5% +$10.3K 0.01% 631
2021
Q3 		$211K Buy
+498
New +$210K 0.01% 644

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Hancock Whitney's WST Position: Q1 2025 in Review

Hancock Whitney sold out of West Pharmaceutical (WST) in Q1 2025, closing a stake of 691 shares — an estimated $226K sold.

Hancock Whitney first reported a position in WST in Q3 2021 and held it in 8 quarters. The position peaked at $9.88M in Q1 2024. 715 funds tracked by Wall St. Rank hold WST as of Q1 2025.

  • Hancock Whitney reported no remaining West Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • Hancock Whitney sold 691 West Pharmaceutical shares in Q1 2025, an estimated $226K.
  • Hancock Whitney first reported a position in West Pharmaceutical in Q3 2021 and held it in 8 quarters.
  • Hancock Whitney's West Pharmaceutical position peaked at $9.88M in Q1 2024.
  • 715 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2025.

Based on Hancock Whitney's 13F filing for Q1 2025, filed 15 May 2025.